论文部分内容阅读
目的:探析使用白三烯拮抗剂联合吸入舒利迭治疗老年哮喘的临床效果。方法:选择我院于2012年11月至2013年11月期间收治的70例哮喘患者作为研究对象,随机分为观察组和对照组。对照组单纯使用舒利迭进行治疗,观察组则联合白三烯拮抗剂和舒利迭进行治疗,比较两组治疗效果。结果:采用白三烯拮抗剂联合吸入舒利迭进行治疗的观察组在肺部功能、炎性介质以及生存质量评分方面的改善程度明显优于对照组,比较具有统计学意义(P<0.05)。结论:使用白三烯拮抗剂联合吸入舒利迭治疗老年哮喘可以有效改善患者的哮喘症状以及活动受限问题,提高患者的生存质量,应用效果显著,值得大力推广。
OBJECTIVE: To investigate the clinical effect of leukotriene antagonist and inhaled seretide in the treatment of senile asthma. Methods: Seventy patients with asthma admitted from November 2012 to November 2013 in our hospital were randomly divided into observation group and control group. The control group was treated with only seretide. The observation group was treated with leukotriene antagonist and seretide. The therapeutic effects of the two groups were compared. Results: The improvement of pulmonary function, inflammatory mediators and quality of life scores in the observation group treated with leukotriene antagonist and inhaled Seretide were significantly better than those in the control group (P <0.05) . Conclusion: The combination of leukotriene antagonist and inhaled Seretide for the treatment of senile asthma can effectively improve the patients’ asthma symptoms and the limitation of activities, and improve the quality of life of patients. The application effect is significant and worthy of promotion.